AACP
Advantage Alpha Capital Partners Portfolio holdings
AUM
$371M
1-Year Return
16.18%
This Quarter Return
+12.05%
1 Year Return
+16.18%
3 Year Return
+64.49%
5 Year Return
+102.68%
10 Year Return
–
AUM
$439M
AUM Growth
-$18.9M
(-4.1%)
Cap. Flow
-$64.9M
Cap. Flow
% of AUM
-14.77%
Top 10 Holdings %
Top 10 Hldgs %
18.42%
Holding
197
New
43
Increased
53
Reduced
70
Closed
31
Top Buys
| 1 |
Advanced Drainage Systems
WMS
|
$8.54M |
| 2 |
Chart Industries
GTLS
|
$5.94M |
| 3 |
HubSpot
HUBS
|
$5.27M |
| 4 |
First American
FAF
|
$5.13M |
| 5 |
Core & Main
CNM
|
$4.13M |
Top Sells
| 1 |
LKQ Corp
LKQ
|
$11.9M |
| 2 |
Varonis Systems
VRNS
|
$5.98M |
| 3 |
SharkNinja
SN
|
$5.52M |
| 4 |
Appian
APPN
|
$5.37M |
| 5 |
BECN
Beacon Roofing Supply, Inc.
BECN
|
$4.68M |
Sector Composition
| 1 | Industrials | 33.93% |
| 2 | Technology | 21.05% |
| 3 | Healthcare | 11.93% |
| 4 | Financials | 10.79% |
| 5 | Consumer Discretionary | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Acadia Pharmaceuticals
ACAD
$4.3B
| $383K | 0.09% |
24,914
-13,160
| -35% | -$202K |
|
152
Madrigal Pharmaceuticals
MDGL
$9.61B
| $349K | 0.08% |
+1,643
| New | +$349K |
|
153
ANI Pharmaceuticals
ANIP
$2.08B
| $344K | 0.08% |
+5,772
| New | +$344K |
|
154
Guardant Health
GH
$7.65B
| $343K | 0.08% |
+14,937
| New | +$343K |
|
155
Collegium Pharmaceutical
COLL
$1.24B
| $341K | 0.08% |
+8,813
| New | +$341K |
|
156
Gyre Therapeutics
GYRE
$688M
| $334K | 0.08% |
+26,634
| New | +$334K |
|
157
Castle Biosciences
CSTL
$670M
| $312K | 0.07% |
+10,940
| New | +$312K |
|
158
Organogenesis Holdings
ORGO
$638M
| $290K | 0.07% |
101,558
-256,896
| -72% | -$735K |
|
|
PSTX
159
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $285K | 0.06% |
+99,566
| New | +$285K |
|
160
Puma Biotechnology
PBYI
$257M
| $276K | 0.06% |
+108,129
| New | +$276K |
|
161
SIGA Technologies
SIGA
$608M
| $276K | 0.06% |
+40,841
| New | +$276K |
|
162
Fennec Pharmaceuticals
FENC
$255M
| $264K | 0.06% |
+52,876
| New | +$264K |
|
163
Definitive Healthcare
DH
$417M
| $262K | 0.06% |
58,505
-363,941
| -86% | -$1.63M |
|
164
ImmunityBio
IBRX
$2.26B
| $257K | 0.06% |
+69,207
| New | +$257K |
|
|
CLYM
165
Climb Bio, Inc. Common Stock
CLYM
$158M
| $245K | 0.06% |
+48,169
| New | +$245K |
|
166
Harvard Bioscience
HBIO
$20.8M
| $63.5K | 0.01% |
+23,617
| New | +$63.5K |
|
167
Boot Barn
BOOT
$5.83B
| – | – |
-20,398
| Closed | -$2.63M |
|
168
Cadre Holdings
CDRE
$1.3B
| – | – |
-70,517
| Closed | -$2.37M |
|
169
Arcosa
ACA
$4.82B
| – | – |
-5,518
| Closed | -$460K |
|
170
Agilon Health
AGL
$501M
| – | – |
-363,978
| Closed | -$2.38M |
|
171
APA Corp
APA
$8.39B
| – | – |
-13,262
| Closed | -$390K |
|
172
Arcturus Therapeutics
ARCT
$455M
| – | – |
-27,040
| Closed | -$658K |
|
173
Choice Hotels
CHH
$5.42B
| – | – |
-24,079
| Closed | -$2.87M |
|
174
Chord Energy
CHRD
$6.15B
| – | – |
-2,529
| Closed | -$424K |
|
175
Civitas Resources
CIVI
$3.29B
| – | – |
-5,924
| Closed | -$409K |
|